#USA #New York #Childhood Cancer #St. Jude #MSIG USA

MSIG USA's Commitment to Curing Childhood Cancer

On September 2, 2025, MSIG USA unveiled its new partnership with St. Jude Children's Research Hospital, aiming to unite efforts in the fight against childhood cancer and other life-threatening diseases. MSIG USA, a prominent player in the insurance industry, is stepping up to play a vital role in St. Jude’s lifesaving mission.

The Lifesaving Mission of St. Jude

Established in 1962, St. Jude Children's Research Hospital is a beacon of hope for children suffering from severe illnesses, particularly cancer. The hospital has achieved remarkable milestones, boosting the survival rate of childhood cancer from just 20% to over 80%. This success stems from its dedicated research and treatment initiatives that prioritize children’s well-being, allowing families to focus on care instead of medical expenses.

“By aligning with St. Jude, we’re not just supporting healthcare; we’re investing in the future well-being of children,” stated Peter McKenna, CEO of MSIG USA. This partnership signifies more than just financial aid; it presents an opportunity for MSIG employees across the country to engage actively with St. Jude through volunteering, fundraising efforts, and events.

Ensuring No Family Receives a Bill

A unique aspect of St. Jude’s approach is its commitment to ensuring that families never receive a bill for treatment, travel, housing, or food costs related to their child’s care. This allows families to dedicate their time entirely to supporting their child without the burden of financial stress. MSIG USA’s involvement will help sustain this vital aspect of St. Jude’s mission.

A Call to Action: The St. Jude Thanks and Giving® Campaign

As part of its nationwide outreach, MSIG USA will partake in the 2025 St. Jude Thanks and Giving® campaign. This initiative brings together many organizations and millions of consumers during the holiday season, emphasizing the importance of supporting life-saving medical research and aiding families in need.

“We are excited to welcome MSIG USA into the St. Jude family,” commented Lyles Eddins, Senior Vice President of Relational Advancement at ALSAC. This collaboration is hoped to enhance the development of crucial research and therapies that could change lives for thousands of children diagnosed with cancer globally each year.

Building a Brighter Future Together

Through this partnership, MSIG USA and St. Jude are dedicated to paving the way for resilience, compassion, and significant progress in treating childhood illnesses. By combining MSIG's robust resources and insurance expertise with St. Jude's innovative research, they aim to turn childhood cancer from a daunting diagnosis into a manageable one.

This endeavor serves as a reminder of the power of collaboration—how joining forces with a common goal can create transformative change in the lives of many. Every step taken together fortifies the hope that no child will have to face the battle against cancer alone.

For more information on MSIG USA's initiatives or St. Jude's groundbreaking work, visit MSIG USA and St. Jude Children's Research Hospital.